A new study suggests that severe COVID infection may help shrink cancer by inducing special monocytes that can fight cancer cells. This offers a potential new approach to cancer treatment that doesn't rely on T cells. Clinical trials are needed to confirm these findings in humans.
Key Points
Induced monocytes with anti-cancer properties shrink tumors in mice
Provides a way to kill tumors independent of T cells
Opens up possibilities for new drugs and vaccines to stimulate cancer-fighting monocytes
Pros
Potential new approach to cancer treatment
Offers hope for patients who don't respond to traditional immunotherapy
Induces special monocytes that can fight cancer cells
Cons
Study conducted in mice, clinical trials needed for human confirmation
Seeking out COVID infection is dangerous and not recommended